Background Tofacitinib is a disease-modifying antirheumatic drug (DMARD) which was recently approved by US Food and Drug Administration (FDA). There are several randomised clinical trials (RCTs ...

A drug typically prescribed for arthritis halts brain-damaging seizures in mice that have a condition like epilepsy, according to researchers at the University of Wisconsin–Madison. The drug ...

The combination of tofacitinib plus zimlovisertib improved outcomes over tofacitinib alone in patients with rheumatoid arthritis. Ritlecitinib failed to show additive efficacy in rheumatoid ...